Expression and function of a stem cell promoter for the murine CBFα2 gene:: Distinct roles and regulation in natural killer and T cell development

被引:79
作者
Telfer, JC [1 ]
Rothenberg, EV [1 ]
机构
[1] CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA
关键词
CBF alpha 2; PEBP2 alpha B; AML1; Runx1; gene expression regulation; development; hematopoietic stem cells; growth and development;
D O I
10.1006/dbio.2000.9991
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The Runt family transcription factor CBF alpha2 (AML1, PEBP2 alphaB, or Runx1) is required by hematopoietic stem cells and expressed at high levels in T-lineage cells. In human T cells CBFa2 is usually transcribed from a different promoter (distal promoter) than in myeloid cells (proximal promoter), but the developmental and functional significance of this promoter switch has not been known. Here, we report that both coding and noncoding sequences of the distal 5' end are highly conserved between the human and the murine genes, and the distal promoter is responsible for the overwhelming majority of CBF alpha2 expression in murine hematopoietic stem cells as well as in T cells. Distal promoter activity is maintained throughout T cell development and at lower levels in B cell development, but downregulated in natural killer cell development. The distal N-terminal isoform binds to functionally important regulatory sites from known target genes with two- to threefold higher affinity than the proximal N-terminal isoform. Neither full-length isoform alters growth of a myeloid cell line under nondifferentiating conditions, but the proximal isoform selectively delays mitotic arrest of the cell line under differentiating conditions, resulting in the generation of greater numbers of neutrophils. (C) 2000 Academic Press.
引用
收藏
页码:363 / 382
页数:20
相关论文
共 89 条
[71]  
Speck NA, 1999, CANCER RES, V59, p1789S
[72]  
STEWART M, 1997, P NATL ACAD SCI USA, V94, P6846
[73]   POSITIVE AND NEGATIVE REGULATION OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR PROMOTER ACTIVITY BY AML1-RELATED TRANSCRIPTION FACTOR, PEBP2 [J].
TAKAHASHI, A ;
SATAKE, M ;
YAMAGUCHIIWAI, Y ;
BAE, SC ;
LU, J ;
MARUYAMA, M ;
ZHANG, YW ;
OKA, H ;
ARAI, N ;
ARAI, K ;
ITO, Y .
BLOOD, 1995, 86 (02) :607-616
[74]   AN ACUTE MYELOID-LEUKEMIA GENE, AML1, REGULATES HEMATOPOIETIC MYELOID CELL-DIFFERENTIATION AND TRANSCRIPTIONAL ACTIVATION ANTAGONISTICALLY BY 2 ALTERNATIVE SPLICED FORMS [J].
TANAKA, T ;
TANAKA, K ;
OGAWA, S ;
KUROKAWA, M ;
MITANI, K ;
NISHIDA, J ;
SHIBATA, Y ;
YAZAKI, Y ;
HIRAI, H .
EMBO JOURNAL, 1995, 14 (02) :341-350
[75]   Cooperation between core binding factor and adjacent promoter elements contributes to the tissue-specific expression of interleukin-3 [J].
Taylor, DS ;
Laubach, JP ;
Nathan, DG ;
MatheyPrevot, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (24) :14020-14027
[76]   Two domains unique to osteoblast-specific transcription factor Osf2/Cbfa1 contribute to its transactivation function and its inability to heterodimerize with Cbfβ [J].
Thirunavukkarasu, K ;
Mahajan, M ;
McLarren, KW ;
Stifani, S ;
Karsenty, G .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (07) :4197-4208
[77]  
Tracey WD, 1998, DEVELOPMENT, V125, P1371
[78]   LYMPHOHEMATOPOIETIC PROGENITORS IMMORTALIZED BY A RETROVIRAL VECTOR HARBORING A DOMINANT-NEGATIVE RETINOIC ACID RECEPTOR CAN RECAPITULATE LYMPHOID, MYELOID, AND ERYTHROID DEVELOPMENT [J].
TSAI, S ;
BARTELMEZ, S ;
SITNICKA, E ;
COLLINS, S .
GENES & DEVELOPMENT, 1994, 8 (23) :2831-2841
[79]  
TUGORES A, 1992, J IMMUNOL, V148, P2300
[80]  
Uchida H, 1997, J IMMUNOL, V158, P2251